AMERIPRISE FINANCIAL INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$18,637,475
+15.8%
693,616
+53.7%
0.01%
+20.0%
Q2 2023$16,094,767
+35.9%
451,339
-3.2%
0.01%
+25.0%
Q1 2023$11,843,474
-42.3%
466,278
-7.8%
0.00%
-42.9%
Q4 2022$20,509,000
+16.9%
505,635
-4.7%
0.01%
+16.7%
Q3 2022$17,543,000
-7.4%
530,773
-1.4%
0.01%
-14.3%
Q2 2022$18,951,000
-23.1%
538,233
+0.4%
0.01%0.0%
Q1 2022$24,656,000
-31.7%
536,131
-1.5%
0.01%
-30.0%
Q4 2021$36,078,000
+16.5%
544,172
+9.7%
0.01%0.0%
Q3 2021$30,977,000
-24.9%
496,197
-0.4%
0.01%
-23.1%
Q2 2021$41,256,000
+26.1%
498,163
+1.0%
0.01%
+18.2%
Q1 2021$32,711,000
-10.4%
493,306
+3.7%
0.01%
-15.4%
Q4 2020$36,501,000
+58.7%
475,682
-10.9%
0.01%
+44.4%
Q3 2020$22,998,000
+21.9%
534,059
+22.3%
0.01%
+12.5%
Q2 2020$18,864,000
+90.0%
436,698
+26.5%
0.01%
+60.0%
Q1 2020$9,930,000
-56.7%
345,165
-4.5%
0.01%
-50.0%
Q4 2019$22,926,000
+50.8%
361,434
-33.0%
0.01%
+42.9%
Q3 2019$15,199,000
+9.7%
539,365
+3.2%
0.01%
+16.7%
Q2 2019$13,854,000
+1385300.0%
522,754
+550167.4%
0.01%
Q4 2018$1,000
-99.9%
95
-99.9%
0.00%
-100.0%
Q3 2018$1,438,000
+821.8%
75,064
+552.7%
0.00%
Q2 2018$156,000
-79.8%
11,500
-97.7%
0.00%
Q4 2016$771,000
-79.3%
498,385
-1.6%
0.00%
-100.0%
Q3 2016$3,724,000
+1.2%
506,565
-26.7%
0.00%0.0%
Q2 2016$3,679,000690,7950.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders